Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Transplant Infection”

317 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 317 results

Not applicableUnknownNCT00701272
What this trial is testing

FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation

Who this might be right for
Liver TransplantationHepatitis C
University Health Network, Toronto 70
Not applicableUnknownNCT01944527
What this trial is testing

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection

Who this might be right for
HCV RecurrenceLiver TransplantationDirect-acting Antiviral Agents
ANRS, Emerging Infectious Diseases 699
Post-approval studies (Phase 4)Ended earlyNCT03625687
What this trial is testing

Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant

Who this might be right for
Respiratory FailureHepatitis C
Massachusetts General Hospital 19
Large-scale testing (Phase 3)Study completedNCT01131065
What this trial is testing

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Who this might be right for
Hepatitis BLiver Transplantation
Instituto Grifols, S.A. 15
Testing effectiveness (Phase 2)Study completedNCT02010255
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Who this might be right for
Chronic HCV Infection
Gilead Sciences 334
Post-approval studies (Phase 4)WithdrawnNCT03026023
What this trial is testing

Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant

Who this might be right for
Cardiac Transplant DisorderHepatitis C
Raymond T. Chung, MD
Not applicableTemporarily pausedNCT02935478
What this trial is testing

Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation

Who this might be right for
ObesityWeight LossBody Weight+4 more
St. Louis University 8
Not applicableLooking for participantsNCT06544863
What this trial is testing

Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants

Who this might be right for
Cirrhosis
Assistance Publique - Hôpitaux de Paris 3,000
Testing effectiveness (Phase 2)Ended earlyNCT00228592
What this trial is testing

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

Who this might be right for
Hepatitis BLiver Transplantation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Post-approval studies (Phase 4)Looking for participantsNCT06958796
What this trial is testing

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Who this might be right for
CytomegalovirusOrgan TransplantKidney Transplant; Complications+2 more
Camille N. Kotton, MD 80
Testing effectiveness (Phase 2)Ended earlyNCT00473824
What this trial is testing

Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation

Who this might be right for
Sequelae of Viral HepatitisTransplantation InfectionEvidence of Liver Transplantation
ADMA Biologics, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT02781571
What this trial is testing

Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 79
Not applicableStudy completedNCT00368225
What this trial is testing

Transplant-Related Accelerated Progression of Hepatitis C

Who this might be right for
Hepatitis CCirrhosis
National Institutes of Health Clinical Center (CC) 100
Large-scale testing (Phase 3)Study completedNCT00140725
What this trial is testing

Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)

Who this might be right for
Chronic Hepatitis B
GlaxoSmithKline 160
Not applicableStudy completedNCT00817908
What this trial is testing

Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients

Who this might be right for
Cytomegalovirus Infection
University of Alberta 131
Very early researchStudy completedNCT03249194
What this trial is testing

Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients

Who this might be right for
Kidney TransplantHepatitis C
Virginia Commonwealth University 25
Not applicableUnknownNCT04281797
What this trial is testing

Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients

Who this might be right for
Transplantation InfectionKidney Transplant; ComplicationsStem Cell Transplant Complications+2 more
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 90
Testing effectiveness (Phase 2)Looking for participantsNCT07630727
What this trial is testing

Study of AHB-171 in Chronic Hepatitis B Participants

Who this might be right for
Hepatitis B, Chronic (CHB)
Ausper Biopharma Co., Ltd. 138
Early research (Phase 1)Study completedNCT01074203
What this trial is testing

A Pilot Study to Examine the Role of Nitazoxanide to Prevent Recurrence of Hepatitis C After Transplantation

Who this might be right for
Hepatitis C Recurrence
Mayo Clinic 8
Not applicableNot Yet RecruitingNCT06542042
What this trial is testing

Application of Nanopore Adaptive Sequencing

Who this might be right for
Liver Transplant Infection
Shenzhen Third People's Hospital 100
Next Page